Verition Fund Management’s Translational Development Acquisition Corp Units TDACU Stock Holding History
Bought
Maintained
Sold
Other funds holding TDACU
MF
RCM
MI
WAM
PMAM
SIA
Verition Fund Management's TDACU Position: Q1 2025 in Review
Verition Fund Management sold out of Translational Development Acquisition Corp Units (TDACU) in Q1 2025, closing a stake of 346,490 shares — an estimated $3.48M sold.
Verition Fund Management first reported a position in TDACU in Q4 2024 and held it in 1 quarter. The position peaked at $3.48M in Q4 2024. 21 funds tracked by Wall St. Rank hold TDACU as of Q1 2025.
- Verition Fund Management reported no remaining Translational Development Acquisition Corp Units position as of Q1 2025 after selling out during the quarter.
- Verition Fund Management sold 346,490 Translational Development Acquisition Corp Units shares in Q1 2025, an estimated $3.48M.
- Verition Fund Management first reported a position in Translational Development Acquisition Corp Units in Q4 2024 and held it in 1 quarter.
- Verition Fund Management's Translational Development Acquisition Corp Units position peaked at $3.48M in Q4 2024.
- 21 funds tracked by Wall St. Rank held Translational Development Acquisition Corp Units as of Q1 2025.
Based on Verition Fund Management's 13F filing for Q1 2025, filed 15 May 2025.